INTRODUCTION: The aim of the study was to retrospectively evaluate the technical features, efficacy, accuracy, and relevant complications of computed tomography-guided biopsies in various anatomical localizations when diagnosing indolent lymphoma transformations, relapses, duplicate malignant diseases or benign processes. MATERIAL AND METHODS: From December 2007 to December 2017, 81 percutaneous biopsy procedures in 72 patients for tumors, sizes 17-232 mm in diameter (median length: 39 mm), were performed in patients with known indolent lymphomas in their clinical history. The patients were men in 41 cases and women in 31 cases, aged 36 to 86 years. RESULTS: In 79 cases (97.5%; 95% CI: 91.3-99.7) results were true positive or true negative; only 2 interventions (2.5%; 95% CI: 0.3-8.6) were histologically false negative. Transformation was verified in 29 cases (35.8%; 95% CI: 25.4-47.2), relapses in 30 cases (37%; 95% CI: 26.6-48.5), duplicate malignancy in 15 cases (18.5%; 95% CI: 10.8-28.7) and benign processes in 7 cases (8.7%; 95% CI: 3.5-17.0). Eight complications in total were revealed, 7 of which were in consequence of thoracic cavity biopsy. A statistically significant relationship between the complication incidence and anatomical localization in the thoracic cavity was identified (p = 0.0104). CONCLUSIONS: Percutaneous CT guided biopsy performed in patients with a history of indolent lymphoma had high accuracy in establishing the correct diagnosis regarding transformation, relapse, duplicate malignancy or a benign process. Simultaneously, the complication rate was low.

Department of Internal Medicine Hematology University Hospital Hradec Kralove Czech Republic

Department of Radiology University Hospital Hradec Kralove Czech Republic

The Fingerland Department of Pathology University Hospital Hradec Kralove Czech Republic

Zobrazit více v PubMed

Smith A, Crouch S, Lax S, et al. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK’s Haematological Malignancy Research Network. Br J Cancer. 2015;112:1575–84. PubMed PMC

Dähnert W. Radiology Review Manual. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 1264.

Law MF, Chan HN, Leung C, et al. Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. Arch Med Sci. 2017;13:698–701. PubMed PMC

Buske C, Hutchings M, Ladetto M, et al. ESMO Lymphoma Consensus Conference Panel Members ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. Ann Oncol. 2018;29:544–62. PubMed

Janikova A, Bortlicek Z, Campr V, et al. The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database. Ann Hematol. 2018;97:669–78. PubMed

Hoshino A, Nomura K, Hamashima T, et al. Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes. Int J Hematol. 2015;101:198–202. PubMed

Casulo C, Friedberg J. Transformation of marginal zone lymphoma (and association with other lymphomas) Best Pract Res Clin Haematol. 2017;30:131–8. PubMed

Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenström macroglobulinemia. Am J Hematol. 2016;91:1032–5. PubMed

Al-Tourah AJ, Gill KK, Chhanabhai M, et al. Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma. J Clin Oncol. 2008;26:5165–9. PubMed

Smolej L, Simkovic M. Practical approach to management of chronic lymphocytic leukemia. Arch Med Sci. 2016;12:448–56. PubMed PMC

Skelton E, Jewison A, Okpaluba C, et al. Image-guided core needle biopsy in the diagnosis of malignant lymphoma. Eur J Surg Oncol. 2015;41:852–8. PubMed

Groneck L, Quaas A, Hallek M, Zander T, Weihrauch MR. Ultrasound-guided core needle biopsies for workup of lymphadenopathy and lymphoma. Eur J Haematol. 2016;97:379–86. PubMed

He Y, Ji X, Xie Y, et al. Clinical application of ultrasound-guided core needle biopsy with multiple punches in the diagnosis of lymphoma. World J Surg Oncol. 2015;13:126. PubMed PMC

de Larrinoa AF, del Cura J, Zabala R, Fuertes E, Bilbao F, Lopez JI. Value of ultrasound-guided core biopsy in the diagnosis of malignant lymphoma. J Clin Ultrasound. 2007;35:295–301. PubMed

Sklair-Levy M, Amir G, Spectre G, et al. Image-guided cutting-edge-needle biopsy of peripheral lymph nodes and superficial masses for the diagnosis of lymphoma. J Comput Assist Tomogr. 2005;29:369–72. PubMed

Pugliese N, Di Perna M, Cozzolino I, et al. Randomized comparison of power Doppler ultrasonography-guided core-needle biopsy with open surgical biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma. Ann Hematol. 2017;96:627–37. PubMed PMC

Ladetto M, Buske C, Hutchings M, et al. the ESMO Lymphoma Consensus Conference Panel Members ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia. Ann Oncol. 2016;27:2149–60. PubMed

Daly SC, Klairmont M, Arslan B, et al. Laparoscopy has a superior diagnostic yield than percutaneous image-guided biopsy for suspected intra-abdominal lymphoma. Surg Endosc. 2015;29:2496–9. PubMed

Sando M, Terasaki M, Okamoto Y, Suzumura K, Tsuchiya T. The utility of diagnostic laparoscopic biopsy for mesenteric and retroperitoneal lymph nodes. Am J Case Rep. 2017;18:878–82. PubMed PMC

Asoglu O, Porter L, Donohue JH, Cha SS. Laparoscopy for the definitive diagnosis of intra-abdominal lymphoma. Mayo Clin Proc. 2005;80:625–31. PubMed

Amador-Ortiz C, Chen L, Hassan A, et al. Combined core needle biopsy and fine-needle aspiration with ancillary studies correlate highly with traditional techniques in the diagnosis of nodal-based lymphoma. Am J Clin Pathol. 2011;135:516–24. PubMed

Kanemasa Y, Shimoyama T, Sasaki Y, et al. Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma. Hematol Oncol. 2017;35:440–6. PubMed

Sarkozy C, Trneny M, Xerri L, et al. Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial. J Clin Oncol. 2016;34:2575–82. PubMed

Falchi L, Keating MJ, Marom EM, et al. Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood. 2014;123:2783–90. PubMed PMC

Yao D, Zhang L, Wu PL, et al. Clinical and misdiagnosed analysis of primary pulmonary lymphoma: a retrospective study. BMC Cancer. 2018;18:281. PubMed PMC